Skip to main content
Premium Trial:

Request an Annual Quote

Rainbow Genomics, UCLA Partner to Offer Exome Dx in Asia

NEW YORK (GenomeWeb) – Rainbow Genomics, a Hong Kong-based genetic testing company, said today that it plans to contract data analysis and clinical interpretation from the University of California, Los Angeles Clinical Genomics Center for its exome-sequencing tests.

Rainbow's exome sequencing tests cover cardiovascular diseases as well as both adult and pediatric genetic disorders. The firm noted that it also covers Asian-specific genes that are not often included in many panel-based gene tests.

Under the alliance, sequencing will be performed at Rainbow's CAP-accredited laboratory, while the UCLA Clinical Genomics Center will deliver clinical reports.

Daniel Siu, CEO of Rainbow Genomics, said in a statement that the relationship between Rainbow and UCLA will enable "many middle-class families to access exceptionally high-quality exome sequencing genetic tests that may finally provide a diagnosis."

Wayne Grody, director of molecular diagnostics at the UCLA Health System, added that Asian countries, despite their "robust economies and impressive technology," have "remained underserved in the areas of genetic testing and genomic medicine."

The Scan

Sensor to Spot SARS-CoV-2 Exposure

Yale researchers have developed a sensor that gauges SARS-CoV-2 exposure, according to the New Haven Register.

Watching BA.2

A subtype of the Omicron SARS-CoV-2 variant has been found in a number of countries, the Washington Post says.

Vermont Weighs Genetic Discrimination Bill

VT Digger reports Vermont legislators are considering a bill to bar insurer from denying customers coverage based on genetic information.

PNAS Papers on Convergent Pathogen Effectors, Lineage-Related RNA Mutations, Desiccation-Tolerant Grass

In PNAS this week: convergent evolution of pathogen effectors, algorithm to identify cell lineage features, and more.